Welcome to LookChem.com Sign In|Join Free

CAS

  • or

959237-92-4

Post Buying Request

959237-92-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

959237-92-4 Usage

Type of compound

Organic compound

Structure

Triazole ring with an isopropyl group attached

Usage

Intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds

Potential

Biological activity, used in medicinal chemistry research

Building block

Can be used in the preparation of various organic compounds

Importance

Versatile and significant chemical in organic synthesis and drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 959237-92-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,2,3 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 959237-92:
(8*9)+(7*5)+(6*9)+(5*2)+(4*3)+(3*7)+(2*9)+(1*2)=224
224 % 10 = 4
So 959237-92-4 is a valid CAS Registry Number.

959237-92-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Isopropyl-1H-1,2,3-triazol-4-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:959237-92-4 SDS

959237-92-4Upstream product

959237-92-4Downstream Products

959237-92-4Relevant articles and documents

PYRROLOPYRIMIDINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF

-

Paragraph 00413, (2017/07/06)

The present disclosure is concerned with certain pyrrolopyrimidine compounds that are capable of inhibiting certain protein kinases, and especially the leucine-rich repeat kinase 2 (LRRK2) protein. Compounds of the present disclosure can be used to treat

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 959237-92-4